MSI-H/ MMRd
Who we are
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
PIPAC for the Treatment of Colorectal Peritoneal Metastases
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors
Partial Liver Segment 2/3 Transplantation Study
